Appointments

866.320.4573

Request an Appointment

Questions

800.223.2273

Contact us with Questions

Expand Content

Thomas Bauer, MD, PhD

216.444.6830

Thomas Bauer, MD, PhD

Appointed: 1983

Thomas Bauer, MD, PhD
Department: Anatomic Pathology
Medical Director of the Biorepository
Location: Cleveland Clinic Main Campus
Mail Code L25
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.6830
WorkFax:216.445.6967
Thomas Bauer, MD, PhD
Department: Center for Spine Health
Location: Cleveland Clinic Main Campus
Mail Code L25
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.6830
WorkFax:216.445.6967
Thomas Bauer, MD, PhD
Department: Orthopaedic Surgery
Location: Cleveland Clinic Main Campus
Mail Code L25
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.6830
WorkFax:216.445.6967
Thomas Bauer, MD, PhD
Department: Pathology and Laboratory Medicine Institute
Medical Director of the Biorepository
Location: Cleveland Clinic Main Campus
Mail Code L25
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.6830
WorkFax:216.445.6967
Surgeon:
No
Treats:
Adults Only

Biographical Sketch

Thomas W. Bauer, MD, PhD, specializes in orthopaedic and gastrointestinal pathology. He holds joint appointments in the Institutes of Orthopaedics and Rheumatology as well as Spine, and his research interests involve mostly orthopaedic biomaterials. 

Dr. Bauer is board-certified in Anatomic and Clinical Pathology. He joined the professional staff of Cleveland Clinic in 1983. His research laboratory investigates the development of new materials and designs in spine and skeletal reconstruction, cartilage repair and total joint arthroplasty, and he is considered an expert in the mechanisms of success and failure of orthopaedic devices.
 
He has given more than 150 invited lectures outside of Cleveland Clinic, he has served as a consultant and voting member to U.S. Food and Drug Administration advisory panels in two different divisions, and he has published more than 225 manuscripts and book chapters. He is also Deputy Editor for Research for The Journal of Bone and Joint Surgery.

Dr. Bauer received MD and PhD degrees from The University of Nebraska College of Medicine and completed a residency in Anatomic and Clinical Pathology at The Johns Hopkins Hospital in Baltimore, Maryland.

Professional Highlights

  • Subspecialty expertise in orthopaedic biomaterials research
  • Deputy Editor for Research for The Journal of Bone and Joint Surgery
  • Consultant to advisory panels for the U.S. Food and Drug Administration related to pathology and orthopedics

Education & Fellowships

Residency - Johns Hopkins Hospital
Anatomical&Clinical Pathology
Baltimore, MD USA
1983
Internship - Johns Hopkins Hospital
Pathology
Baltimore, MD USA
1980
Medical School - University of Nebraska College of Medicine
Omaha, NE USA
1979
Undergraduate - University of Colorado
Biology
Boulder, CO USA
1972

Certifications

  • Anatomic & Clinical Pathology
  • Pathology Recertification

Specialty Interests

biomaterials, metabolic bone disease, orthopaedic pathology, Metabolic Bone Disease, bone and soft tissue pathology

Memberships

  • Orthopaedic Research Society
  • Society for Biomaterials
  • The Hip Society
  • Arthur Purdy Stout Society of Surgical Pathologists

Treatment & Services

  • Orthopaedic Pathology

Specialty in Diseases and Conditions

  • Metabolic Bone Disease
  • Spine Pain

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 5/16/2014, Dr. Bauer has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Bauer receives fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

  • Stryker Corporation

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English